Theralase Technologies Inc. (TLT)
TSXV
0.1750
-0.0050 (-2.78%)
Closed
Oct 9, 2026
Day's Range
0.17500.1800
52 wk Range
0.15000.4100
Financial Statements - TLT - Theralase Technologies Inc.
Revenue
816.46K▼ 21.0%
Net Income
-4.12M▲ 3.2%Net Margin -504.7%
EBITDA
-3.83M▲ 3.0%
Free Cash Flow
-3.33M▲ 0.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 816.46K | 1.03M | 1.07M | 1.13M | 780.64K | 929.12K |
| Cost of Goods | 309.33K | 479.40K | 508.17K | 510.39K | 470.69K | 659.44K |
| Gross Profit | 507.13K | 554.02K | 562.13K | 628.17K | 309.94K | 269.68K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -4.17M | -4.28M | -4.59M | -5.23M | -4.54M | -5.69M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 17.29K | -10.08K | 3.98K | -13.17K | 113.16K | 4.16K |
| Pre Tax Income | -4.12M | -4.25M | -4.57M | -5.23M | -4.41M | -5.59M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -4.12M | -4.25M | -4.57M | -5.23M | -4.41M | -5.59M |
| EPS Basic | -0.016 | -0.018 | -0.022 | -0.025 | -0.022 | -0.027 |
| EPS Diluted | -0.016 | -0.018 | -0.022 | -0.025 | -0.022 | -0.027 |
| Basic Shares Outstanding | 253.13M | 240.06M | 219.96M | 207.92M | 204.27M | 204.27M |
| Diluted Shares Outstanding | 253.13M | 240.06M | 219.96M | 207.92M | 204.27M | 204.27M |
| Ebit | -4.07M | -4.23M | -4.54M | -5.21M | -4.40M | -5.58M |
| Ebitda | -3.83M | -3.94M | -4.25M | -4.88M | -4.24M | -5.32M |
| Net Income Continuous Operations | -4.12M | -4.25M | -4.57M | -5.23M | -4.41M | -5.59M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
